GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Byotrol PLC (LSE:BYOT) » Definitions » COGS-to-Revenue

Byotrol (LSE:BYOT) COGS-to-Revenue : 0.58 (As of Sep. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Byotrol COGS-to-Revenue?

Byotrol's Cost of Goods Sold for the six months ended in Sep. 2023 was £1.17 Mil. Its Revenue for the six months ended in Sep. 2023 was £2.02 Mil.

Byotrol's COGS to Revenue for the six months ended in Sep. 2023 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Byotrol's Gross Margin % for the six months ended in Sep. 2023 was 41.99%.


Byotrol COGS-to-Revenue Historical Data

The historical data trend for Byotrol's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Byotrol COGS-to-Revenue Chart

Byotrol Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.52 0.57 0.55 0.60

Byotrol Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.63 0.51 0.68 0.58

Byotrol COGS-to-Revenue Calculation

Byotrol's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2.733 / 4.592
=0.60

Byotrol's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.173 / 2.022
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Byotrol  (LSE:BYOT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Byotrol's Gross Margin % for the six months ended in Sep. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1.173 / 2.022
=41.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Byotrol COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Byotrol's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Byotrol (LSE:BYOT) Business Description

Traded in Other Exchanges
Address
Building 303 (Ashton), Pool Lane, Thornton Science Park, Ince, Chester, GBR, CH2 4NU
Byotrol PLC is a developer of consumer and professional antimicrobial technologies and products. It is engaged in the development, patenting, licensing, and sale of anti-microbial products and technologies for business and consumer use. It operates in two reportable segments, being Professional (including Human Health, Animal Health, Facilities Management, and Food & Beverage), and Consumer (Including Household, Skin Care, and Pet Care). Its customers are based in the UK, North America, Asia, and the Rest of the World. The company generates key revenue from product sales - sale of anti-microbial technology and includes Royalty and licensing income.

Byotrol (LSE:BYOT) Headlines

No Headlines